FAQ
Glossary
Facility Locator
What's New
Site Help
Index A-Z
Contact Us
Email Updates
Report a Safety Concern
Nuclear Reactors
Power Reactors
Research & Test Reactors
Operating Reactors
New Reactors
Operator Licensing
Research Activities
Nuclear Reactor Quick Links
Nuclear Materials
Special Nuclear Material
Source Material
Byproduct Material
Med, Ind, & Academic Uses
Radium
Uranium Recovery
Fuel Cycle Facilities
Materials Transportation
Research Activities
Nuclear Materials Quick Links
Radioactive Waste
Decommissioning of Nuclear Facilities
Low-Level Waste
Waste Incidental to Reprocessing
High-Level Waste
Uranium Mill Tailings
Low-Level Waste Disposal
High-Level Waste Disposal
Storage of Spent Nuclear Fuel
Transportation of Spent Nuclear Fuel
Research Activities
Radioactive Waste Quick Links
Nuclear Security
Domestic Safeguards
Information Security
Radioactive Material Security
Required Reporting for Clearance Holders
Insider Threat Program for Licensees
Criminal History & Firearms Checks
Contact Us
Public Meetings & Involvement
The NRC Approach to Open Government
About Meetings Open to the Public
Conferences & Symposia
Documents for Comment
NRC Rules and Petitions
Facilitating Stakeholder Involvement
NRC Information Quality Guidelines
Subscribe to E-mail Updates
Commission Schedule
Public Meeting Schedule
Adjudications (Hearings)
Adjudicatory Submissions
NRC Library
Basic References
Document Collections
ADAMS Public Documents
Public Document Room
LSN Library
FOIA & Privacy Act
Photos & Videos
Records Management
Training Courses
FAQ Index
Get Copies of Documents
Withholding of Sensitive Information
Controlled Unclassified Information Program (CUI)
Electronic Hearing Docket
About NRC
The Commission
Organization & Functions
Governing Legislation
Plans, Budget, & Performance
Locations
History
Values
Direction-Setting & Policymaking
Research Activities
Radiation Protection
Fire Protection
Safety Culture
How We Regulate
Emergency Preparedness & Response
Public Affairs
Congressional Affairs
Enforcement
International Programs
State & Tribal Programs
Alternative Dispute Resolution Programs
Privacy Program
Civil Rights
Contact Us
Career Opportunities
Contracting Opportunities
Small Businesses
Grant Opportunities
Generic Schedules
Other Links
Other Links
FAQ
Glossary
Facility Locator
What's New
Site Help
Index A-Z
Contact Us
Email Updates
NRC Facebook
NRC Twitter Feed
NRC Linkedin
NRC Youtube Channel
NRC Flickr Gallery
NRC Blog Archived
NRC Email Subscriptions - GovDelivery
Print
Home
Public Involvement
About Meetings Open to the Public
Public Meeting Schedule
Print
Public Meeting Schedule: Meeting Details
[
New Search
]
Meeting info
Purpose
The objectives of this FDA-NRC workshop are: 1) Develop collaborative approaches among stakeholders in development of new drug products and devices with emphasis on addressing unmet medical needs for serious and life-threatening conditions. 2) Expedite regulatory reviews and increase the overall efficiency of the development process to ensure timely access for patients to emerging therapies. Topics for Discussion: -Overview of Regulatory Process for Marketing and Licensing of Radiopharmaceutical Devices -Novel Radiopharmaceuticals: physical standards development, product quality considerations, supply and demand -Safety and Efficacy Considerations for Radiopharmaceutical Products -The Evolving Landscape—Radiological Devices -Clinical Trial Design Considerations for Radiopharmaceuticals Please see the FDA's Website for additional information: https://www.fda.gov/drugs/news-events-human-drugs/fda-nrc-workshop-enhancing-development-emerging-technologies-radiopharmaceuticals-and-radiological
Meeting Feedback
Meeting Dates and Times
* Date/Time Change *
10/14/20
8:00AM - 5:00PM
Webinar
Webinar Link:
https://usnrc.webex.com/usnrc/onstage/g.php?MTID=eabeba69a55ff5fc6faf8d90db0b2e450
Webinar Meeting Number:199 171 3631
Webinar Password:FDA-NRC
Contact
Sarah Lopas, NRC
(301) 415-6360
Lisa Dimmick, NRC
(301) 415-0694
Participation Level
Category 3
NRC Participants
Office of Nuclear Material Safety and Safeguards
External Participants
US Food and Drug Administration
Docket Numbers - Facility Names
Related Documents
ML20281A547
- Agenda for October 14, 2020 Collaborative Workshop FDA-NRC: Enhancing Development of Novel Technologies - Radiopharmaceutical and Radiological Devices
ML20283A345
- 10/14/2020 U.S. Food and Drug Administration (FDA) and U.S. Nuclear Regulatory Commission (NRC) WorkshopEnhancing Development of Novel Technologies: Radiopharmaceuticals and Radiological Devices
Comments
The October 14th workshop will be conducted using Cisco WebEx. To participate in the workshop, please pre-register using the webinar link provided above. In addition to WebEx, a live webcast of the workshop WebEx will be available at https://video.nrc.gov/
Page Last Reviewed/Updated Friday, November 19, 2021
Section Navigation
Navigation
Search Public Meetings
Recent Public Meetings
Meeting Detail
Welcome and Help
Attendee Information
System Notices
Hours of Operation
Contact Us About Public Meetings
Spotlight
Choose a Section
NIST Test Reactor Event
Mission Analytics Portal
NRC COVID-19 Update
Transformation at the NRC - Updated
OIG Hotline
Rulemaking Activity
New Reactor Construction - Vogtle
Accident Tolerant Fuel
Commission Documents
Advanced Reactors
Nuclear Security
NRC Safety Culture Policy Statement
Strategic Plan
For Employees